Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v4-EN
Language English English
Date Updated 2017-12-02 2017-03-16
Drug Identification Number 01908286 01908286
Brand name IMOVAX RABIES RABIES VACCINE INACTIVATED (DCO) IMOVAX RABIES RABIES VACCINE INACTIVATED (DCO)
Common or Proper name Rabies Vaccine Inactivated (DCO) Rabies Vaccine Inactivated (DCO)
Company Name SANOFI PASTEUR LIMITED SANOFI PASTEUR LIMITED
Ingredients RABIES VACCINE INACTIVATED RABIES VACCINE INACTIVATED
Strength(s) 2.5UNIT 2.5UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1.0 mL single dose vial with 1 mL diluent / Fiole de 1,0 mL à dose unique avec 1 mL de diluant 1.0 mL single dose vial with 1 mL diluent / Fiole de 1,0 mL à dose unique avec 1 mL de diluant
ATC code J07BG J07BG
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Requirements related to complying with good manufacturing practices. Disruption of the manufacture of the drug.
Anticipated start date 2017-11-22 2017-03-16
Actual start date 2017-11-22 2017-03-16
Estimated end date 2017-12-15 Unknown
Actual end date 2017-12-01
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Sanofi Pasteur has been experiencing a supply shortage of IMOVAX® Rabies vaccine. We anticipate resuming supply by mid-December 2017. Supply disruptions are anticipated in the private market.
Health Canada comments